CVS to Cover Lilly’s GLP-1 Medications, Expanding Access
CVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Choosing cash back over points can lead to immediate savings. Find out the best scenarios to maximize your financial benefits.
27,195 articlesCVS Health will broaden coverage for Lilly’s GLP-1 medications, including the new pill Foundayo and Zepbound injectio...
Purchase applications rose 7% week over week and 17% year over year, even as mortgage rates hover near cycle highs. A...
Meta Platforms is accelerating its real-time ai push, aiming to turn data streams into immediate monetization. With 2...
A clear look at how Vanguard Health Care and iShares Biotechnology compete for space in a diversified portfolio. Lear...
Two hugely popular fixed-income ETFs sit at the heart of many portfolios: TLT and LQD. This guide breaks down their d...
Ethereum has seen price swings as reports surface that ethereum founder vitalik buterin has been selling portions of ...
Goldman Sachs says AI hasn’t raised productivity across the economy, but two targeted use cases show a median 30% gai...
Jim Cramer’s take on Power Solutions International’s sharp drop spotlights a potential entry point for data center-re...
Palantir's chief technology officer raised alarms about U.S. weapon stock levels in a recent discussion, prompting re...
The White House extended the deadline for Iran to reopen the Strait of Hormuz to April 6, sparking a fresh wave of oi...
ZachXBT alleges insider control as LAB token scrutiny rises amid an investigation into AI Terminal's $6 billion FDV p...
The Strategic Petroleum Reserve posted what may be its largest weekly withdrawal, about 10 million barrels, pushing s...